Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Clinical outcomes associated with tislelizumab in patients (pts) with advanced hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (SOR) or lenvatinib (LEN) in RATIONALE-208Edeline, Julien ; Merle, Philippe ; Fang, Weijia ; Assenat, Eric ; Pan, Hongming ; Rimassa, Lorenza ; Li, Zhiwei ; Blanc, Jean-Frédéric ; Yen, Chia-Jui ; Ross, Paul J. ; Hu, Sheng ; Zhang, Tao ; Tran, Albert ; Shao, Guoliang ; Bouattour, Mohamed ; Chen, Yajin ; Wu, John ; Li, Vincent ; Chica-Duque, Sandra ; Ren, ZhenggangJournal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4072-4072 [Periódico revisado por pares]Texto completo disponível |
|
2 |
Material Type: Artigo
|
Clinical outcomes associated with tislelizumab in patients (pts) with advanced hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (SOR) or lenvatinib (LEN) in RATIONALE-208Edeline, Julien ; Merle, Philippe ; Fang, Weijia ; Assenat, Eric ; Pan, Hongming ; Rimassa, Lorenza ; Li, Zhiwei ; Blanc, Jean-Frederic ; Yen, Chia-Jui ; Ross, Paul J. ; Hu, Sheng ; Zhang, Tao ; Tran, Albert ; Shao, Guoliang ; Bouattour, Mohamed ; Chen, Yajin ; Wu, John ; Li, Bai ; Chica-Duque, Sandra ; Ren, ZhenggangJournal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.420-420 [Periódico revisado por pares]Texto completo disponível |